Skip to main content
. 2023 Jun 23;12:e43788. doi: 10.2196/43788

Table 1.

Schedule of postimplementation evaluations.

Study day Baseline assessment (day 1) Final assessment (month 6)

EHRa Pathway Platform Pathway Platform EHR
Demographic characteristics b
Number of PHQ-9c scores documented
Treatment adjustments
Referral to behavioral health
PHQ-9 scores
EDd visits
ED visits due to mental illness
Hospital admissions
Follow-up after ED and hospital visits
Hospital admissions due to mental illness
Outpatient visits, including phone calls
Outpatient visits, including phone calls due to mental illness
Remission and response (using PHQ-9 data)
PAM-13e
CollaboRATE
WSASf
PHQ-9
WHO-5g
PDQ-D-5h
DSSTi
Medication adherence
Side effects
PSD-6j (only if reporting side effects of sleep problems)
ASEXk (only if reporting side effects of sexual problems)
Goal setting
Goal attainment
App analytics
Report analytics
Educational material analytics
AEsl or SAEsm,n

aEHR: electronic health record.

b—: Not available.

cPHQ-9: 9-item Patient Health Questionnaire.

dED: emergency department.

ePAM-13: 13-item Patient Activation Measure.

fWSAS: Work and Social Adjustment Scale.

gWHO-5: 5-item World Health Organization Well-being Index.

hPDQ-D-5: 5-item Perceived Deficits Questionnaire–Depression.

iDSST: Digit Symbol Substitution Test.

jPSD-6: Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance 6a.

kASEX: Arizona Sexual Experience Scale.

lAE: adverse event.

mSAE: serious adverse event.

nDuring the conduct of the study, adverse events or serious adverse events will be reported. As such, reports will be spontaneously notified, and causality of any AEs will be assumed unless there is evidence to the contrary.